Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
58 results about "Topical cream" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Beneficial Effects of Increasing Local Blood Flow
InactiveUS20090105336A1Increase oxygenationImprove tissue nutritionBiocideOrganic active ingredientsTopical creamArginine
The present invention provides a treatment for enhancing the ability of the body to heal wounds. A topical cream is described which improves blood flow by the transdermal delivery of the nitric oxide precursor L-Arginine either alone or with an adjunct, theophylline. The delivery of the active agents is accomplished by use of a vehicle which contains a hostile biophysical environment which is also hostile to hydrogen bond formation.
Owner:STRATEGIC SCI & TECH
Restorative skin cream
This invention relates to topical creams which retard sun exposure damage to skin and restore skin health. More particularly, this invention pertains to a novel topical skin cream formulation which retards sun damage to skin and restores skin health comprising: (a) vitamin A retinyl at a concentration of 0.2% to 10% weight, and / or retinol at a concentration of 0.2% to 10% weight; (b) vitamin C at a concentration of 5 % to 30% weight; (c) vitamin E at a concentration of 1% to 10% weight; (d) zinc sulfate at a concentration of 2% to 5% weight; and (e) the remainder, water and skin compatible thickeners, emulsifiers, emollients and moisturizers, having a pH of about 3 to 6.
Owner:TELFORD HLDG
Methods and compositions for administering a specific wavelength phototherapy
ActiveUS20140121732A1Avoid lightCosmetic preparationsHair cosmeticsDosimeterElectromagnetic radiation
Methods are disclosed for administering electromagnetic radiation (EMR), which may include filtering EMR from part of the EMR spectrum while allowing passage of EMR at a desired wavelength range. Uses may include the treatment of such conditions as psoriasis, vitiligo, pruritus, acne, vitamin-D deficiency and atopic dermatitis. Topical creams, sprays, or other compositions may be used, with or without dosimeters, or in conjunction with an application, which calculates local UV exposure and other factors relating to dosage.
Owner:JUPITER WELLNESS INC
B complex vitamin compositions that protect against cellular damage caused by ultraviolet light
InactiveUS7018623B2Reduces UV damageReduce riskBiocideCosmetic preparationsVitamin K2Immune depression
The present invention relates generally to the use of vitamin B12 (cobalamin or cyanocobalamin) alone or in combination with other photoprotective agents, including specifically other vitamins such as vitamin B9 (folic acid or folate) and vitamin B3 (niacin or niacinamide), or any chemical derivative of these vitamins and their salts, as a filter to protect cells against the damaging effects of ultraviolet (UV) light. The invention is, in one aspect, a method of reducing the rate of UV damage to cells exposed to a UV light source, by treating the cells with the vitamin composition, either alone or in combination with other photoprotective agents. Other aspects of the invention are compositions comprising effective amounts of vitamin B12 alone or in combination with other photoprotective agents including vitamin B9 and vitamin B3 and a pharmaceutically-acceptable carrier, that are useful in protecting cells, particularly skin cells, against the burning, genotoxic (mutagenic and carcinogenic), immunosuppressive and photoaging effects of UV light, especially sunlight. The invention has application as a UV light filter in oral preparations including tablets and drinks, topical creams, lotions, sprays, wipes and cosmetics. The invention also has application as a medicinal treatment for dermatological conditions caused by exposure to sunlight, such as actinic keratoses, photodermatitis, photo-induced (discoid) lupus erythematosus and the photosensitizing effects of a variety of drugs used commonly in clinical practice (e.g. certain antihistamines, ACE inhibitors, and antibiotics such as tetracycline).
Owner:BARCLAY BARRY J
Topical cream and method of making same
A topical cream includes a water mixture, calendula infused olive oil, cassia oil, geranium oil, and wax. The cream optionally, but preferably, includes grapeseed or olive oil, frankincense oil, myrrh oil, and a violet fragrance. The water mixture preferably includes rosewater and a small amount of glycerin. The cream is made by mixing and heating predetermined amounts of the oils to produce a hot oil mixture. The wax, preferably in grated form, is added to the hot oil mixture to produce a creamy wax mixture. The wax mixture is cooled and blended with the water mixture and fragrance (when used) to produce the cream. The cream provides medicinal, cosmetic, therapeutic, and / or spiritual benefits.
Owner:LERMA SHELAH M
A novel anti-aging skincare cream, the cosmetic device and cream within
This invention reveals a novel skin-rejuvenating method that combines the application of light physics (a Light emitting diode (LED) device with specific wavelength, intensity, and pulsing frequency) and biochemistry (a specific collagenase inhibitor). The programmed LED light can penetrate skin epidermis and activate the fibroblasts in dermis to produce new collagen. Meanwhile, the overproduction of collagen leads to the feedback activation of collagenase, which degrades collagen and eliminates the beneficiary effects of LED light. Hence, this invention also includes a topical cream containing a certain lipophilic collagenase inhibitor, which, when used alone or in combination with the light device, can maintain high levels of skin collagen, and eventually achieve the long term effects of reducing wrinkles, enhancing skin elasticity, and diminishing eye bags and dark circles. The light device and active-containing cream have achieved positive effects when tested in human trials.
Owner:YOLARE DERMACEUTICALS
Body tissue and skin treatment method using pulsing heating pad and topical cream
InactiveUS20040073258A1Increase blood flowGood skin permeabilitySalicyclic acid active ingredientsHeart defibrillatorsSweat glandHigh blood flow
A body tissue treatment system comprising a heating device and a topical cream comprises controlled, non-burning heat exhibiting greater temperature fluctuation than a conventional heating device. At high temperature settings, the heating elements fluctuate widely between a relatively high maximum and low minimum to produce periods of intense heat input into the skin followed by sufficient cooling to prevent burning of the skin. Such application of intense heat to the skin, for short periods in which temperatures reach their peaks, relaxes musculature surrounding the injured area and significantly improves blood flow, skin permeability, and sweat gland openness in the area, which allows the topical cream to more readily penetrate skin and / or injured body tissues. While the skin temperature rises and falls to some extent in response to the heating device, the intense heating periods are believed to cause such high blood flow and consequent heat transfer away from the skin surface that the skin temperature does not rise to the extent of being damaged or burned.
Owner:FIREFLY INT
Anhydrous topical formulation for polyphenols
Owner:ORIGIN BIOMEDICINALS
Low-dose mometasone formulations
InactiveUS20100029602A1Unique and elegant and safe and effectiveUnique and elegant and safe and effective compositionOrganic active ingredientsOintment deliveryTopical creamSteroid responsive
Provided is a topical cream composition for the delivery of mometasone furoate comprising low dose mometasone furoate for the treatment of corticosteroid responsive dermatoses. The composition of the present invention can be safely applied over large surface areas of the skin (including areas with wrinkles and / or hair), and can be used therapeutically for extended periods of time (e.g., greater than 3 weeks). Treatment with the composition of the present invention carries reduced and / or fewer side effects compared with commercially available mometasone furoate cream products. The cream composition of the present invention is safe for the use of babies and infants under 2 years old. Additionally provided are methods of preparing and using the composition of the invention.
Owner:AGIS INDUSTRIES (1983) LTD
Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness
InactiveUS20160317480A1Reduce painReduce inflammationHydroxy compound active ingredientsSulfur/selenium/tellurium active ingredientsBursitisAdditive ingredient
A Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness which alleviates pain and inflammation from muscle strain, spasms, arthritis, and bursitis. The composition and method for alleviation of pain and inflammation generally includes a combination of Lidocaine HCL, camphor, menthol, Bisabolol, glucosamine hydrochloride (glucosamine HCI), chondroitin, and MSM, along with a number of other ingredients. The composition described and claimed herein has been shown to alleviate pain and inflammation from injuries and conditions such as muscle strains, spasms, arthritis, and bursitis. The composition will preferably be incorporated into a topical cream which may be applied to the skin around the affected area to provide not only immediate relief from pain and inflammation, but also long-lasting relief which may last for days or even weeks.
Owner:BROCKMAN NICHOLAS ADAM
Anhydrous topical formulation for polyphenols
The present invention discloses a composition of matter, and method to formulate same, which is an anhydrous topical cream, gel or ointment base, a polyphenol and a suitable adsorbent binding carrier to which the polyphenol will bind for purposes of even disbursement within the cream, gel or base and which will not inhibit the ability of the polyphenols to be released on and into the aqueous environment of the skin when the topical mixture is applied thereto. The binding carrier provides the ability to disperse a hydrophilic polyphenol in a non-aqueous medium for purposes of topical application to the body. In particular, the present invention discloses the use of polyphenols such as tea catechins, and in particular green tea catechins, disbursed in an anhydrous base consisting of either saturated or unsaturated plant oils or waxes through the use of a variety of binding carriers including, but is not limited to, talcs and clays, alginates, algae, agars, gums, gelatins, celluloses, silica, silica gels, simethicone, salicylates, silicates and silicone resins, tragacanths, calcium carbonates and magnesium or zinc oxides. Such binding carriers are particularly useful when polyphenol concentrations exceed 0.2% w / w in the mixture, and their use is preferred when concentrations are between 1.0 to 20% w / w polyphenols.
Owner:ORIGIN BIOMED
Clothing with non-permeable liners
An article of clothing (14), such as shorts (2), shirts (7), leggings (10), arm sleeves (11), etc., having an outer layer of material (3) and an inner non-permeable liner (1) that either temporarily attaches to the outer layer by a temporary attachment means (15) or permanently attaches to the outer layer by a permanent attachment means (16). The inner non-permeable liner prevents topical creams applied to a user's skin from evaporating off of the user's skin. The inner non-permeable liner is available in different shapes to cover the different areas of the skin that patients have hair removed from. The outer layer is preferably made out of a material having elastomeric qualities that will ensure that the non-permeable liner is pressed firmly against the skin of a user. The outer perimeter (13) of the non-permeable liner may have a raised edge (4) and / or elastic (5) to ensure that the any cream applied to the skin of a user does not escape out of the sides of the non-permeable liner.
Owner:MORRIS SHANNON C
Treatment of hypoactive sexual disorder (HSDD)
A topical cream to be applied to the clitoris and hood of the vaginal area to create an intense libido and drive for orgasm. The cream comprises a base cream having from about 9.5% to about 10%, by volume, of a steroid, based upon the total volume of the cream. Preferably, at least about 1% to about 10% by volume, of the steroid, based on the total volume of the cream. The topical cream may, also, include from about 0.1% to about 2.0%, by volume, of oxytocin. The addition of the small amount thereof enhances the efficacy of the cream.
Owner:LICHTEN EDWARD M
Compositions and formulations of glucosamine for transdermal and transmucosal administration
ActiveUS9012430B2Moderate efficacyReduced bioavailabilityBiocideSulfur/selenium/tellurium active ingredientsTopical creamSuppository
Disclosed are compositions and formulations comprising glucosamine or a pharmaceutically acceptable salt thereof for use in the treatment of joint conditions and adapted for use in a bath or soak or bath beads, powders, salts, and oils, kits, and methods of treatment using the same. Also disclosed are lozenges, suppositories, patches, and topical creams comprising glucosamine or a pharmaceutically acceptable salt thereof for use in the treatment of joint conditions and methods of treatment using the same. In some embodiments the joint conditions include osteoarthritis.
Owner:VITAL MEDICINE
Method of Enhancing Health of a Person
InactiveUS20140242185A1Improve performanceRelieve sorenessBiocideEnergy modified materialsTopical creamAutoimmune condition
A method of enhancing health of a person includes administering stable water clusters to persons having an autoimmune disease, pain, a chronic disease, a mental disease, a genetic disease from malfunction of a normal DNA, being an athlete for improving his performance and alleviating soreness, suffering from overworking, stress and toxins etc., by drinking a solution containing stable water clusters, swallowing small objects which contain the stable water clusters, putting a topical cream which contains the stable water clusters on skin, breathing the stable water clusters through mouth, putting drops which contain the stable water clusters into eyes, ears or nose, cleaning colon with solution that contains the stable water clusters, eating food that contains the stable water clusters, injecting solution that contain the stable water clusters into blood vessel etc.
Owner:D&Y TECH
Compositions and formulations of glucosamine for transdermal and transmucosal administration
ActiveUS20140031312A1Moderate efficacyReduced bioavailabilityBiocideSugar derivativesTopical creamSuppository
Disclosed are compositions and formulations comprising glucosamine or a pharmaceutically acceptable salt thereof for use in the treatment of joint conditions and adapted for use in a bath or soak or bath beads, powders, salts, and oils, kits, and methods of treatment using the same. Also disclosed are lozenges, suppositories, patches, and topical creams comprising glucosamine or a pharmaceutically acceptable salt thereof for use in the treatment of joint conditions and methods of treatment using the same. In some embodiments the joint conditions include osteoarthritis.
Owner:VITAL MEDICINE
Canna and Shea Topical Cream
InactiveUS20120027701A1Relieve painEffective treatmentCosmetic preparationsBiocideTopical creamButter cocoa
A THC composition comprises cannabis leaves simmered in butter, which is then filtered and cooled, and then mixed with shea butter. The resulting compound is used for topical skin relief, sun protection for skin and other uses. The butter used for simmering the cannabis leaves may be cow butter, sheep butter, olive oil, cooking oil, and other compositions.
Owner:STONE SONYA
Use of transglutaminase inhibitor in skin treatment
InactiveUS20110034556A1Prevent agingReduce usageCosmetic preparationsBiocideTopical creamSkin treatments
Human skin is treated for cosmetic purposes, in particular for the management of skin irritation and / or inflammation as well as inhibiting ageing effects, which result therefrom by using a topical cream containing at least one transglutaminase inhibitor such as putrescine.
Owner:DOLYNCHUK KENNETH NICHOLIS
Tofacitinib and baclofen compositions and applications
The human body is mediated by a large number of chemicals and chemical processes where imbalances can result in abnormal conditions affecting part or all of the human body. Artificial drugs addressing specific diseases by targeting specific chemical imbalance(s) and / or process(es). For example, tofactinib is a JAK-STAT signaling pathway inhibitor beneficial for treating autoimmune diseases whilst baclofen acts as an agonist of GABA receptors. However, these are each prescribed in oral form leading to reduced efficacy or absorption by other regions of the patient. Accordingly, the inventor has established alternate dosing formats such a topical creams allowing local direct application allowing specific targeted delivery to the appropriate region of the patient's body as well their use, in the instances of tofactinib and baclofen, for the treatment of other diseases or conditions.
Owner:HANNA ANDREW
Water-Gel Emulsion Compositions and Methods
A water-based composition containing oil soluble components may include an anhydrous concentrate and a hydration component, which may be stored in separate vessels prior to mixing. The anhydrous concentrate may be combined with the hydration component to create a consumer product such as a topical cream. The anhydrous concentrate may include a preparation that includes a liquid dispersion polymer, an inverting surfactant and a binding agent, and also may include lipid-soluble vitamins, antioxidants and the like. The hydration component may include water and a preservative system, and also may include water-soluble vitamins, antioxidants and the like. Two forms (i.e. lipid-soluble and water-soluble) of a given ingredient (such as vitamin C) may be provided in the concentrate and the hydration component, respectively. A third vessel may be used for mixing the concentrate with the hydrator and / or dispensing the concentrate, the hydrator and / or the consumer product.
Owner:CONCEPT LAB
Topical Formulation for Binding to Dermatological Cannabinoid Receptors
ActiveUS20180360770A1Small amountHydrocarbon active ingredientsHydroxy compound active ingredientsTopical creamYlang-ylang
A topical cream or ointment is provided that provides for the binding to CB1 and / or CB2 receptors for the soothing of dermatological itching. The cream or ointment composition provides the effect of cannabinoids without the actual use of cannabinoids. Several essential oils, including Black Pepper, Ylang Ylang, and Melissa essential oils in combination, contain caryophyllene, a sesquiterpene, in effective amounts to bind to the CB2 receptor and help reduce an urge to itch the skin.
Owner:KADO JESSICA
Ccr5 antagonists as prophylactics for preventing HIV infection and methods of inhibiting transmission of same
Topical cream, ointment, lotion, gel, foam formulations and slow release formulations or devices are provided including certain CCR5 antagonists as prophylactics for the prevention, retardation or inhibition of transmission of Human Immunodeficiency Virus (HIV) infection from one human to another.
Owner:MERCK SHARP & DOHME CORP
Canna and Shea topical cream
Owner:STONE SONYA
Cannabinoid and Terpene-Infused Topical Cream
ActiveUS20200085959A1Good moisturizing effectEffective roles in anti-inflammatory skin diseasesHydroxy compound active ingredientsAerosol delivery2-Pyrrolidone-5-Carboxylic AcidTopical cream
Owner:FREEZE CODY D +1
Composition and Method of Skin Relief Cream useful for Eczema, Psoriasis, Lipoma, Burn Wounds, Scars, Keloids, Shingles, Dry Skin Disorders, and Skin Allergies.
ActiveUS20200061144A1Effective treatmentCosmetic preparationsSalicyclic acid active ingredientsEczematous rashAllergy
The present invention relates generally to a herbal cream formulation useful for treatment of skin diseases and disorders, therapeutic and cosmetic applications. More specifically, the present invention relates to the composition of a topical cream useful for treating Eczema, Psoriasis, burn wounds, scars, keloids, Lipomas, Shingles, dry skin disorders, skin allergies and other related skin diseases. The present invention includes the composition and method of making the topical cream.
Owner:LADDHA UNMESH DWARKANATH
Topical formulation for binding to dermatological cannabinoid receptors
ActiveUS10543176B2Hydrocarbon active ingredientsHydroxy compound active ingredientsTopical creamCaryophyllene
Owner:KADO JESSICA
Finasteride and sildenafil compositions and applications
InactiveUS20190282591A1Dissolve fastOrganic active ingredientsPharmaceutical delivery mechanismPhosphodiesteraseHuman body
The human body is mediated by a large number of chemicals and chemical processes where imbalances can result in an abnormal condition that affects part or all of the human body. Amongst these conditions are hair loss and male impotence or erectile dysfunction, both of which can have psychological consequences for the patient and others as they can be tied to relationship difficulties and self-image. 5α-reductase Type II inhibitors prevent DHT production and reduce androgen activity in key tissues such as prostate and scalp. Similarly, an inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) can lead to improved vasodilation and blood flow. It would be beneficial to provide patients with either of these treatments within a topical cream form allowing localized targeted delivery.
Owner:BLUE GOOSE DRUGS INC
Bone fracture analgesic ointment
InactiveCN1233381CIncrease contentRaise pain thresholdAnthropod material medical ingredientsAntipyreticMyrrhInternal injury
Owner:崔澄渤
Compound topical cream and application thereof
InactiveCN104490870AFast stabilityImprove stabilityOrganic active ingredientsAerosol deliverySide effectTreatment effect
The invention belongs to the field of topical medicines and particularly relates to a compound topical cream and application thereof. The compound topical cream is mainly prepared from ftibamzone, lidocaine or an acceptable pharmaceutical salt thereof and a pharmaceutically acceptable excipient. The long-term practice of the inventor shows that ftibamzone and lidocaine can be used together for resisting herpes virus and relieving pain, can take effect quickly and can act synergistically to achieve an unexpected effect. The compound topical cream provided by the invention can be used for resisting herpes virus, relieving pain and itching and treating herpes simplex and herpes zoster effectively and has the functions of alleviating pain, astringing, protecting, diminishing inflammation, preventing anabrosis and reddening and resisting irritation. In addition, the compound topical cream can improve the stability of ftibamzone, can be well absorbed by a human body, can take effect quickly, can ensure that wounds scab quickly, can reduce the suffering of patients, has a strong pain relieving effect, a high cure rate, a significant treatment effect and a little side effects, is convenient to use and is safe and simple.
Owner:HEFEI YIFAN PHARMA MANAGEMENT
Eczema treatment with vitamin D and analogs thereof method, composition and cream
InactiveUS20100081637A1Quick reliefGood moisturizing effectBiocideOrganic active ingredientsVitamin d 3Ergocalciferol
An eczema treatment method comprises application of a therapeutically effective composition in the form of an aqueous topical cream to an affected area of an exterior skin region of a patient, the aqueous topical cream comprising water, a water-soluble organic liquid, a surface active agent, and vitamin D3 compound or another claimed analog thereof, the vitamin D3 compound or the analog constituting at least approximately 10 international units per gram (IU / gram), and, most preferably at least approximately 400 IU / gram. An eczema treatment composition comprises a therapeutically effective formulation comprising at least approximately 50%-90% water, between approximately 1-5% PEG-40 stearate, between approximately 1-5% steareth-2, and cholecalciferal at a concentration of at least approximately 50 international units per gram (IU / g) of composition, and, most preferably at least approximately 400 IU / g. A topical vitamin D cream for therapeutic treatment of eczema includes vitamin D or an analog thereof chosen from the group consisting of cholecalciferol, alfacalcidol, calcifedol, and ergocalciferol; water; a water-soluble organic liquid; and a surface active agent, the vitamin D or analog being in a concentration of at least approximately 50 international units per gram (IU / g) of cream. Remarkably, relief from eczema conditions occurs immediately or in less than 3 days.
Owner:INNOVIA SKINCARE CORP
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com